Evidence map›Paper›PMID 16849509›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2006

The adenosine system selectively inhibits TLR-mediated TNF-alpha production in the human newborn.

Ofer Levy, Melissa Coughlin, Bruce N Cronstein, Rene M Roy, Avani Desai, Michael R Wessels

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 127 papers.

0numbers the graph read from it
0cells of the map it votes in
127citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

127 citing papers in PubMed, 234 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Innovative micro physiological systems for vaccine development.Human vaccines & immunotherapeutics · 2025
    Review
  9. Article
  10. Article
  11. Sex-based differences in persistent lung inflammation following influenza infection of juvenile outbred mice.American journal of physiology. Lung cellular and molecular physiology · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

67 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Ofer LevyInfectious Diseases, Children's Hospital, Boston, MA 02115, USA. ofer.levy@childrens.harvard.edu
Melissa Coughlin
Bruce N Cronstein
Rene M Roy
Avani Desai
Michael R Wessels
Boston Children's Hospital · USBoston Children's Museum · USNew York University · US

Funding

Adenosine Shapes Neonatal Toll-like Receptor FunctionR01AI067353 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI LEVY, OFER · 2006 to 2010
$2.1M
Determinants of Innate Immunity to Group B StreptococciK08AI050583 · NIAID · CHILDREN'S HOSPITAL BOSTON · PI LEVY, OFER · 2002 to 2005
$491k
NIAID NIH HHS K08 AI050583NIAID NIH HHS K08 AI50583-01NIAID NIH HHS R01 AI067353
6 · The paper itself

Abstract

Human newborns are susceptible to microbial infection and mount poor vaccine responses, yet the mechanisms underlying their susceptibility are incompletely defined. We have previously reported that despite normal basal expression of TLRs and associated signaling intermediates, human neonatal cord blood monocytes demonstrate severe impairment in TNF-alpha production in response to triacylated (TLR 2/1) and diacylated (TLR 2/6) bacterial lipopeptides (BLPs). We now demonstrate that in marked contrast, BLP-induced synthesis of IL-6, a cytokine with anti-inflammatory and Th2-polarizing properties, is actually greater in neonates than adults. Remarkably, newborn blood plasma confers substantially reduced BLP-induced monocyte synthesis of TNF-alpha, while preserving IL-6 synthesis, reflecting the presence in neonatal blood plasma of a soluble, low molecular mass inhibitory factor (<10 kDa) that we identify as adenosine, an endogenous purine metabolite with immunomodulatory properties. The neonatal adenosine system also inhibits TNF-alpha production in response to whole microbial particles known to express TLR2 agonist activity, including Listeria monocytogenes, Escherichia coli (that express BLPs), and zymosan particles. Selective inhibition of neonatal TNF-alpha production is due to the distinct neonatal adenosine system, including relatively high adenosine concentrations in neonatal blood plasma and heightened sensitivity of neonatal mononuclear cells to adenosine A3 receptor-mediated accumulation of cAMP, a second messenger that inhibits TLR-mediated TNF-alpha synthesis but preserves IL-6 production. We conclude that the distinct adenosine system of newborns polarizes TLR-mediated cytokine production during the perinatal period and may thereby modulate their innate and adaptive immune responses.

Indexed as

AdenosineAdenosine A3 Receptor AntagonistsAdenosine DeaminaseAdultBacterial ProteinsCyclic AMPFetal BloodHumansImmunologic FactorsInfant, NewbornInterleukin-6Leukocytes, MononuclearLipopeptidesLipoproteinsMacrophage ActivationOligopeptides2,3-bis(palmitoyloxy)-2-propyl-N-palmitoyl-cysteinyl-seryl-seryl-asparaginyl-alanineAdenosineAdenosine A3 Receptor AntagonistsAdenosine DeaminaseBacterial ProteinsCyclic AMPImmunologic FactorsInterleukin-6LipopeptidesLipoproteinsOligopeptidesReceptor, Adenosine A3Toll-Like ReceptorsTumor Necrosis Factor-alpha

Identifiers

PMID16849509
PMCPMC2881468
OpenAlexW1599185640

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.